These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9668197)

  • 41. 3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter.
    Holmquist CR; Keverline-Frantz KI; Abraham P; Boja JW; Kuhar MJ; Carroll FI
    J Med Chem; 1996 Oct; 39(21):4139-41. PubMed ID: 8863789
    [No Abstract]   [Full Text] [Related]  

  • 42. The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates.
    Howell LL; Wilcox KM
    J Pharmacol Exp Ther; 2001 Jul; 298(1):1-6. PubMed ID: 11408518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter.
    Simoni D; Roberti M; Rondanin R; Baruchello R; Rossi M; Invidiata FP; Merighi S; Varani K; Gessi S; Borea PA; Marino S; Cavallini S; Bianchi C; Siniscalchi A
    Bioorg Med Chem Lett; 2001 Mar; 11(6):823-7. PubMed ID: 11277529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the benztropine analog [
    Tomlinson MJ; Krout D; Pramod AB; Lever JR; Newman AH; Henry LK; Vaughan RA
    Neurochem Int; 2019 Feb; 123():34-45. PubMed ID: 30125594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and pharmacology of site specific cocaine abuse treatment agents: 8-substituted isotropane (3-azabicyclo[3.2.1]octane) dopamine uptake inhibitors.
    Kim DI; Schweri MM; Deutsch HM
    J Med Chem; 2003 Apr; 46(8):1456-64. PubMed ID: 12672245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
    Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
    Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GBR compounds and mepyramines as cocaine abuse therapeutics: chemometric studies on selectivity using grid independent descriptors (GRIND).
    Benedetti P; Mannhold R; Cruciani G; Pastor M
    J Med Chem; 2002 Apr; 45(8):1577-84. PubMed ID: 11931612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter.
    Zou MF; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2003 Jul; 46(14):2908-16. PubMed ID: 12825932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.
    Gordon I; Weizman R; Rehavi M
    Eur J Pharmacol; 1996 Feb; 298(1):27-30. PubMed ID: 8867915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain.
    Letchworth SR; Smith HR; Porrino LJ; Bennett BA; Davies HM; Sexton T; Childers SR
    J Pharmacol Exp Ther; 2000 May; 293(2):686-96. PubMed ID: 10773045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives.
    Lomenzo SA; Izenwasser S; Katz JL; Terry PD; Zhu N; Klein CL; Trudell ML
    J Med Chem; 1997 Dec; 40(26):4406-14. PubMed ID: 9435910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potent and selective ligands for the dopamine transporter (DAT): structure-activity relationship studies of novel 4-[2-(diphenylmethoxy)ethyl]-1-(3-phenylpropyl)piperidine analogues.
    Dutta AK; Coffey LL; Reith ME
    J Med Chem; 1998 Feb; 41(5):699-705. PubMed ID: 9513598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.
    Choi SW; Elmaleh DR; Hanson RN; Fischman AJ
    J Med Chem; 2000 Jan; 43(2):205-13. PubMed ID: 10649976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
    Cao J; Kulkarni SS; Husbands SM; Bowen WD; Williams W; Kopajtic T; Katz JL; George C; Newman AH
    J Med Chem; 2003 Jun; 46(13):2589-98. PubMed ID: 12801223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cocaine inhibits the release of MPP+ but not dopamine through the rat dopamine transporter.
    Kitayama S; Morita K; Dohi T
    Eur J Pharmacol; 1996 Aug; 309(1):107-9. PubMed ID: 8864700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine.
    Desai RI; Kopajtic TA; Koffarnus M; Newman AH; Katz JL
    J Neurosci; 2005 Feb; 25(8):1889-93. PubMed ID: 15728828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
    Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
    J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RTI-352: a 3 alpha analogue of RTI-55 as an in vivo dopamine transporter binding ligand.
    Zhan Y; Saindane AM; Scheffel U; Carroll FI; Holmquist CR; Kepler JA; Taylor GF; Kuhar MJ
    Synapse; 1997 Apr; 25(4):389-92. PubMed ID: 9097398
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label.
    Dutta AK; Fei XS; Vaughan RA; Gaffaney JD; Wang N; Lever JR; Reith ME
    Life Sci; 2001 Mar; 68(16):1839-49. PubMed ID: 11292062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.